4.6 Article

Proteomic identification of proteins differentially expressed following overexpression of hTERT (human telomerase reverse transcriptase) in cancer cells

Journal

PLOS ONE
Volume 12, Issue 7, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0181027

Keywords

-

Ask authors/readers for more resources

Reverse transcriptase activity of telomerase adds telomeric repeat sequences at extreme ends of the newly replicated chromosome in actively dividing cells. Telomerase expression is not detected in terminally differentiated cells but is noticeable in 90% of the cancer cells. hTERT ( human telomerase reverse transcriptase) expression seems to promote invasiveness of cancer cells. We here present proteomic profiles of cells overexpressing or knocked down for hTERT. This study also attempts to find out the potential interacting partners of hTERT in cancer cell lines. Two-dimensional gel electrophoresis (2-DE) of two different cell lines U2OS ( a naturally hTERT negative cell line) and HeLa revealed differential expression of proteins in hTERT over-expressing cells. In U2OS cell line 28 spots were picked among which 23 spots represented upregulated and 5 represented down regulated proteins. In HeLa cells 21 were upregulated and 2 were down regulated out of 23 selected spots under otherwise identical experimental conditions. Some heat shock proteins viz. Hsp60 and Hsp70 and GAPDH, which is a housekeeping gene, were found similarly upregulated in both the cell lines. The upregulation of these proteins were further confirmed at RNA and protein level by real-time PCR and western blotting respectively.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Translationally controlled tumor protein (TCTP) is required for TGF-β1 induced epithelial to mesenchymal transition and influences cytoskeletal reorganization

Deepak Kumar Mishra, Pratibha Srivastava, Amod Sharma, Ramraj Prasad, Soubhagya Kumar Bhuyan, Rahuldev Malage, Pramod Kumar, Pramod Kumar Yadava

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2018)

Article Biochemistry & Molecular Biology

hTERT promotes tumor progression by enhancing TSPAN13 expression in osteosarcoma cells

Rishi K. Jaiswal, Pramod Kumar, Manoj Kumar, Pramod K. Yadava

MOLECULAR CARCINOGENESIS (2018)

Article Medicine, Research & Experimental

KLF4 sensitizes the colon cancer cell HCT-15 to cisplatin by altering the expression of HMGB1 and hTERT

Suresh Singh Yadav, Manoj Kumar, Akhil Varshney, Pramod Kumar Yadava

LIFE SCIENCES (2019)

Article Infectious Diseases

Emergence of Haitian variant genotype and altered drug susceptibility in Vibrio cholerae O1 El Tor-associated cholera outbreaks in Solapur, India

Pramod Kumar, Priti Yadav, Kishor Ingole, Rishi K. Jaiswal, Nasira S. Khalid, Durgesh G. Deshmukh, Ajay K. Goel, Pramod K. Yadava

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

Article Multidisciplinary Sciences

Most frequent South Asian haplotypes of ACE2 share identity by descent with East Eurasian populations

Anshika Srivastava, Rudra Kumar Pandey, Prajjval Pratap Singh, Pramod Kumar, Avinash Arvind Rasalkar, Rakesh Tamang, George van Driem, Pankaj Shrivastava, Gyaneshwer Chaubey

PLOS ONE (2020)

Review Microbiology

Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium

Shruti Ahlawat, Pramod Kumar, Hari Mohan, Sandeep Goyal, Krishna Kant Sharma

Summary: The human gut microbiota plays a crucial role in host health, with alterations in composition leading to the development of gastrointestinal disorders. Modulating gut microbiota composition and utilizing advanced treatment methods are key approaches for managing gut disorders in the future.

CRITICAL REVIEWS IN MICROBIOLOGY (2021)

Review Biotechnology & Applied Microbiology

Recent advances on DNA and omics-based technology in Food testing and authentication: A review

Pramod Kumar, Alka Rani, Shalini Singh, Anuj Kumar

Summary: The authentication of food is a pressing issue due to the growing population and direct impact of food on public health. DNA and omics-based methods, such as genomics, metabolomics, and proteomics, are increasingly used in food industry for authentication purposes, detecting adulteration, determining food quality, and identifying allergens, toxins, and carcinogens. Novel methods like CRISPR-Cas have shown potential in enhancing production of beneficial microorganisms and controlling damaging pathogens relevant to food. These methods enable the detection of source, adulteration, mislabeling, and allergens in food products.

JOURNAL OF FOOD SAFETY (2022)

Review Endocrinology & Metabolism

Microbiome and Development of Ovarian Cancer

Aditi Dhingra, Divyani Sharma, Anuj Kumar, Shalini Singh, Pramod Kumar

Summary: Cancer of the female reproductive system, particularly ovarian cancer, is a deadly disease that is often undiagnosed until its later stages. Environmental, genetic, and microbial factors play a significant role in the development of this cancer. The microbial diversity and richness in the reproductive tract and gut are important factors that contribute to the risk of developing ovarian carcinoma.

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2022)

Article Microbiology

A Regional Pooling Intervention in a High-Throughput COVID-19 Diagnostic Laboratory to Enhance Throughput, Save Resources and Time Over a Period of 6 Months

Prerna Mandhan, Mansi Sharma, Sushmita Pandey, Neha Chandel, Nidhi Chourasia, Amit Moun, Divyani Sharma, Rubee Sukar, Niyati Singh, Shubhangi Mathur, Aarti Kotnala, Neetu Negi, Ashish Gupta, Anuj Kumar, R. Suresh Kumar, Pramod Kumar, Shalini Singh

Summary: An effective and rapid diagnosis is crucial in controlling the COVID-19 pandemic by isolating infected individuals and providing specialized treatment. Enhanced testing capacity has been proven to effectively curb the transmission of SARS-CoV-2 during the initial phases of outbreaks. However, the cost of molecular diagnosis limits diagnostic capacity in resource-limited countries. This study introduces two pooling strategies, P-5 and P-10, to improve throughput and save resources and time in a high-throughput COVID-19 diagnostic laboratory.

FRONTIERS IN MICROBIOLOGY (2022)

Article Biochemistry & Molecular Biology

Elucidation of Antiviral and Antioxidant Potential of C-Phycocyanin against HIV-1 Infection through In Silico and In Vitro Approaches

Pratiksha Jadaun, Chandrabhan Seniya, Sudhir Kumar Pal, Sanjit Kumar, Pramod Kumar, Vijay Nema, Smita S. Kulkarni, Anupam Mukherjee

Summary: The study found that C-Phycocyanin (C-PC) can inhibit HIV-1 replication and reduce the generation of mitochondrial ROS. The results showed a strong interaction between C-PC and HIV-1 proteins, and its mechanism of action was through the inhibition of reverse transcriptase and protease enzymes. Additionally, C-PC treatment reduced the production of ROS and the activation of caspase-3/7 in HIV-1-infected cells.

ANTIOXIDANTS (2022)

Article Public, Environmental & Occupational Health

Insights from establishing a high throughput viral diagnostic laboratory for SARS-CoV-2 RT-PCR testing facility: challenges and experiences

Sanchita Roy Pradhan, M. H. Yashavarddhan, Ashish Gupta, Pramod Kumar, Anuj Kumar, Nazneen Arif, Usha Agrawal, R. Suresh Kumar, Shalini Singh

Summary: The Indian Council of Medical Research (ICMR) established a high-throughput viral diagnostic laboratory (HTVDL) during the COVID-19 pandemic to expand testing capacity and adopt rapid testing procedures. The HTVDL provided testing support in two regions of India with a capacity of 6000 tests per day. This article shares the experience of establishing a high-throughput laboratory in developing countries like India and is helpful globally for setting up HTVDLs.

FRONTIERS IN PUBLIC HEALTH (2023)

Letter Infectious Diseases

Vibrio cholerae O1 with ctxB7 variant genotype acquired qnrVC mediated ciprofloxacin resistance in Yavatmal, India

P. Kumar, P. Yadav, D. G. Deshmukh, P. A. Bulle, D. Singh, N. Singh, K. K. Sharma, M. Jain, K. V. Ingole, A. K. Goel, P. K. Yadava

CLINICAL MICROBIOLOGY AND INFECTION (2017)

No Data Available